Janus Henderson Group’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
Other funds holding RLAY
Janus Henderson Group's RLAY Position: Q3 2026 in Review
Janus Henderson Group increased its Relay Therapeutics (RLAY) stake by 25% in Q3 2026, buying an estimated $221K and bringing the position to 57,797 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1758.
Janus Henderson Group first reported a position in RLAY in Q3 2020 and has held it in 23 quarters since. The position peaked at $20.7M in Q3 2020. 261 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.
- Janus Henderson Group held 57,797 shares of Relay Therapeutics worth $1.04M as of Q3 2026.
- Janus Henderson Group bought 11,524 Relay Therapeutics shares in Q3 2026, an estimated $221K.
- Relay Therapeutics made up ﹤0.01% of Janus Henderson Group's portfolio in Q3 2026, its #1758 holding.
- Janus Henderson Group first reported a position in Relay Therapeutics in Q3 2020 and has held it in 23 quarters since.
- Janus Henderson Group's Relay Therapeutics position peaked at $20.7M in Q3 2020.
- 261 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.
Based on Janus Henderson Group's 13F filing for Q3 2026, filed 16 Nov 2026.